MeSH term
Frequency | Condition_Probility | Adult | 14 | 0.0 |
Comparative Study | 20 | 0.0 |
Humans | 83 | 0.0 |
Aged | 10 | 0.0 |
Aged, 80 and over | 5 | 0.0 |
Female | 29 | 0.0 |
Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 4 | 0.0 |
Immunohistochemistry | 6 | 0.0 |
Lymphatic Metastasis | 6 | 0.0 |
Male | 10 | 0.0 |
Metalloendopeptidases/*analysis | 3 | 50.0 |
Middle Aged | 12 | 0.0 |
Neoplasm Staging | 5 | 0.0 |
Predictive Value of Tests | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 63 | 0.0 |
Tumor Markers, Biological/*analysis | 2 | 0.0 |
Breast Neoplasms/*enzymology/pathology | 3 | 9.0 |
Coculture Techniques | 2 | 0.0 |
Culture Media, Conditioned | 2 | 0.0 |
Immunoenzyme Techniques | 3 | 0.0 |
In Situ Hybridization | 9 | 0.0 |
Metalloendopeptidases/*biosynthesis | 3 | 14.0 |
Prognosis | 11 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Amino Acid Sequence | 13 | 0.0 |
Base Sequence | 12 | 0.0 |
Metalloendopeptidases/*genetics | 11 | 12.0 |
Molecular Sequence Data | 19 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Sequence Homology, Amino Acid | 7 | 0.0 |
Tumor Cells, Cultured | 10 | 0.0 |
Metalloendopeptidases/*metabolism | 3 | 3.0 |
Tumor Markers, Biological/metabolism | 2 | 0.0 |
Cell Division | 2 | 0.0 |
DNA, Neoplasm | 2 | 1.0 |
Metalloendopeptidases/*biosynthesis/genetics | 2 | 12.0 |
Animals | 37 | 0.0 |
Child | 4 | 0.0 |
Mice | 18 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
Virus Shedding | 2 | 8.0 |
*Antigens, Viral | 5 | 35.0 |
Capsid/genetics | 2 | 8.0 |
*Capsid Proteins | 11 | 9.0 |
DNA Primers/genetics | 2 | 0.0 |
Evolution, Molecular | 2 | 0.0 |
Genes, Viral/genetics | 2 | 8.0 |
Phylogeny | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Rotavirus Infections/epidemiology/*virology | 3 | 100.0 |
Capsid/*genetics | 4 | 20.0 |
Rotavirus/*classification/*genetics/isolation & purification | 2 | 100.0 |
Serotyping | 9 | 4.0 |
Variation (Genetics) | 2 | 0.0 |
Apoptosis/*physiology | 2 | 0.0 |
Mice, Inbred BALB C | 3 | 0.0 |
Genotype | 2 | 0.0 |
Infant, Newborn | 4 | 0.0 |
RNA, Viral/analysis | 2 | 0.0 |
Rotavirus/classification/*genetics | 3 | 100.0 |
Sequence Alignment | 2 | 0.0 |
Genes, Viral | 4 | 1.0 |
Rotavirus/*genetics | 3 | 75.0 |
Metalloendopeptidases/*genetics/*metabolism | 3 | 42.0 |
Binding Sites | 2 | 0.0 |
Catalytic Domain | 2 | 0.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
Breast Neoplasms/*genetics | 3 | 0.0 |
Carcinogenicity Tests | 2 | 2.0 |
Mice, Nude | 4 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Collagenases/genetics | 2 | 10.0 |
RNA, Messenger/analysis | 4 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 3 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
Adolescent | 3 | 0.0 |
Antibodies, Viral/blood | 2 | 1.0 |
Capsid/*immunology | 2 | 15.0 |
Cattle | 4 | 0.0 |
Child, Preschool | 2 | 0.0 |
Infant | 4 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
Rotavirus/*immunology | 5 | 62.0 |
Vaccination | 3 | 1.0 |
Vaccines, Synthetic/*immunology | 2 | 7.0 |
Hamsters | 2 | 0.0 |
Matrilysin | 3 | 27.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 7 | 0.0 |
Blotting, Northern | 5 | 0.0 |
Gelatinase A | 2 | 2.0 |
Survival Rate | 2 | 0.0 |
Cloning, Molecular | 8 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Gene Expression | 5 | 0.0 |
Disease-Free Survival | 2 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Time Factors | 2 | 0.0 |
Cell Line | 12 | 0.0 |
*DNA-Binding Proteins | 2 | 0.0 |
Promoter Regions (Genetics)/*genetics | 2 | 0.0 |
RNA, Messenger/genetics | 4 | 0.0 |
Pregnancy | 3 | 0.0 |
Recombination, Genetic | 3 | 0.0 |
Follow-Up Studies | 3 | 0.0 |
Metalloendopeptidases/genetics/*metabolism | 3 | 8.0 |
RNA, Messenger/biosynthesis | 3 | 0.0 |
Virus Replication | 3 | 0.0 |
Breast Neoplasms/*enzymology | 3 | 4.0 |
RNA/analysis | 2 | 0.0 |
Cytokines/pharmacology | 2 | 0.0 |
*Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Mutation | 2 | 0.0 |
RNA, Viral/*genetics | 2 | 4.0 |
Cercopithecus aethiops | 2 | 0.0 |
Viral Vaccines/*immunology | 2 | 8.0 |
Blotting, Western | 2 | 0.0 |
Furin | 2 | 4.0 |
Rats | 2 | 0.0 |
Recombinant Proteins/biosynthesis/genetics | 2 | 2.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Transfection | 7 | 0.0 |
Tumor Markers, Biological | 3 | 0.0 |
Enzyme Activation/drug effects | 2 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
RNA/genetics/metabolism | 2 | 1.0 |
Cell Line, Tumor | 2 | 0.0 |
Breast Neoplasms/*pathology | 2 | 0.0 |
*Gene Expression | 3 | 0.0 |
Neoplasm Invasiveness | 4 | 0.0 |
Recombinant Proteins/biosynthesis | 2 | 0.0 |
Transplantation, Heterologous | 2 | 0.0 |
Antibody Specificity | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Fibroblasts/enzymology | 2 | 1.0 |
Dental Plaque/microbiology | 2 | 14.0 |
Neoplasm Metastasis | 3 | 0.0 |
Capsid Proteins | 3 | 16.0 |
Cross Reactions | 2 | 0.0 |
Epitopes/immunology | 2 | 0.0 |
Hydrolysis | 2 | 0.0 |
Neutralization Tests | 7 | 1.0 |
Rotavirus Infections/microbiology | 2 | 100.0 |
Feces/microbiology | 3 | 4.0 |
Viral Vaccines/administration & dosage/adverse effects/*immunology | 2 | 100.0 |
*Capsid | 2 | 66.0 |
*Genes, Viral | 5 | 2.0 |
Nucleic Acid Hybridization | 3 | 0.0 |
Capsid/*genetics/immunology | 2 | 66.0 |
Signal Transduction/drug effects | 2 | 0.0 |
